Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Simonetta

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2022
IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitorToshihito Hirai, Po-Yu Lin, Teresa L Ramos, et al.
Frontiers in Immunology|June 16, 2020
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell TransplantationAmandine Pradier, Stavroula Masouridi-Levrat, Carine Bosshard, et al.
Frontiers in Immunology|December 16, 2024
Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case reportChiara Bernardi, Yan Beauverd, Thien An Tran, et al.
British Journal of Haematology|December 9, 2025
A high-throughput bone marrow 3D co-culture system to study resistance to BCR signalling targeted agents in B-NHLAlex Zadro, Alberto Arribas, Maria Vittoria Colombo, et al.
Blood Advances|July 5, 2022
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHDZunyu Xiao, Israt S Alam, Federico Simonetta, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Viruses|April 28, 2023
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients PlasmaMarie-Céline Zanella, Diem-Lan Vu, Krisztina Hosszu-Fellous, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-PrimingFederico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, et al.
JCI Insight|July 8, 2021
Imaging alloreactive T cells provides early warning of organ transplant rejectionToshihito Hirai, Aaron T Mayer, Tomomi W Nobashi, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 28, 2022
IL-2 receptor engineering enhances regulatory T cell function suppressed by calcineurin inhibitorToshihito Hirai, Po-Yu Lin, Teresa L Ramos, et al.
Frontiers in Immunology|June 16, 2020
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell TransplantationAmandine Pradier, Stavroula Masouridi-Levrat, Carine Bosshard, et al.
Frontiers in Immunology|December 16, 2024
Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case reportChiara Bernardi, Yan Beauverd, Thien An Tran, et al.
British Journal of Haematology|December 9, 2025
A high-throughput bone marrow 3D co-culture system to study resistance to BCR signalling targeted agents in B-NHLAlex Zadro, Alberto Arribas, Maria Vittoria Colombo, et al.
Blood Advances|July 5, 2022
ICOS immunoPET enables visualization of activated T cells and early diagnosis of murine acute gastrointestinal GvHDZunyu Xiao, Israt S Alam, Federico Simonetta, et al.
Leukemia & Lymphoma|July 7, 2017
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantationFederico Simonetta, Stavroula Masouridi-Levrat, Yan Beauverd, et al.
The Lancet. Haematology|May 25, 2024
Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMTSimona Pagliuca, Christoph Schmid, Nicole Santoro, et al.
Viruses|April 28, 2023
Longitudinal Detection of Twenty DNA and RNA Viruses in Allogeneic Hematopoietic Stem Cell Transplant Recipients PlasmaMarie-Céline Zanella, Diem-Lan Vu, Krisztina Hosszu-Fellous, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-PrimingFederico Simonetta, Juliane K Lohmeyer, Toshihito Hirai, et al.
JCI Insight|July 8, 2021
Imaging alloreactive T cells provides early warning of organ transplant rejectionToshihito Hirai, Aaron T Mayer, Tomomi W Nobashi, et al.
Pageof 8